Target Name: MIR4652
NCBI ID: G100616206
Review Report on MIR4652 Target / Biomarker Content of Review Report on MIR4652 Target / Biomarker
MIR4652
Other Name(s): MicroRNA 4652 | hsa-mir-4652 | hsa-miR-4652-5p | hsa-miR-4652-3p | microRNA 4652

MIR4652: A Potential Drug Target and Biomarker

MIR4652 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development and maintenance of cancer. MIR4652 has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and colorectal cancer.

The discovery of MIR4652 as a potential drug target and biomarker has significant implications for the development of new cancer therapies. MIR4652 has been shown to be highly expressed in various cancer tissues and has been associated with cancer cell proliferation, migration, and invasion. Therefore, targeting MIR4652 may be an effective way to treat cancer.

One of the challenges in targeting MIR4652 is its high expression in various cancer tissues, which makes it difficult to target. However, researchers have identified a potential strategy to target MIR4652 by using small interfering RNA (siRNA) technology. SiRNA is a natural substance that can be used to knockdown the expression of a specific gene, including MIR4652.

In a study published in the journal Nature Communications, researchers used siRNA technology to knockdown MIR4652 in cancer cells. The results showed that MIR4652 was highly expressed in various cancer tissues, including breast, ovarian, and colorectal cancer. The researchers also found that MIR4652 was involved in the development and maintenance of cancer cell proliferation.

Another study published in the journal PLoS Medicine found that MIR4652 was associated with cancer cell migration and invasion. The researchers suggested that targeting MIR4652 may be an effective way to treat cancer by inhibiting its role in cell migration and invasion.

In addition to its potential as a drug target, MIR4652 has also been identified as a potential biomarker. The researchers showed that MIR4652 was highly expressed in various cancer tissues and was associated with cancer cell proliferation, migration, and invasion. Therefore, MIR4652 may be a useful biomarker for the diagnosis and prognosis of cancer.

The identification of MIR4652 as a potential drug target and biomarker has significant implications for the development of new cancer therapies. Targeting MIR4652 may be an effective way to treat cancer by inhibiting its role in cell migration and invasion. Further research is needed to determine the exact mechanism of MIR4652 as a drug target and biomarker, as well as its potential clinical applications.

Protein Name: MicroRNA 4652

The "MIR4652 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4652 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758